Backed by top-tier investors from Silicon Valley and Europe, Eligo is an industry-leading biotechnology company, co-founded by scientists from MIT and the Rockefeller University – …
Eligo Bioscience develops a new class of biotherapeutics called Eligobiotics® that enable precision-editing of the microbiome. These phage-derived particles deliver synthetic DNA p…